ALEXION PHARMACEUTICALS, INC. — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2020)

$6.1B

Net Income/Loss (FY2020)

$603.4M

Total Assets (FY2020)

$18.1B

Total Equity (FY2020)

$11.7B

Cash Flows from Operating Activities (FY2020)

$3.0B

Source: ALEXION PHARMACEUTICALS, INC. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.